All.Can International will be represented at the National Cancer Conference BJCN-MORE 2024, scheduled for October 17th–20th, 2024, where Eduardo Pisani, CEO of All.Can International, will participate in the panel discussion: “Artificial Intelligence in Cancer Care: Sustainable System Solutions – Innovative Approaches for Efficiency.”
This session, moderated by George Kapetanakis, President of the Hellenic Cancer Federation (ELLOK), will explore AI-driven solutions in oncology, addressing key areas such as:
- Collaborative innovation across stakeholders,
- Sustainable system solutions to enhance care efficiency,
- Developing policy frameworks that support ethical AI use,
- Building the necessary infrastructure for AI adoption,
- Ensuring equity and accessibility in AI-powered cancer care.
Register here 👉 https://conference-more.bjcn.bg/registracziya/
Cancer care remains one of the most significant challenges for both healthcare systems and patients worldwide, demanding innovative and sustainable solutions to improve outcomes. As we approach this major event, the need to focus on solutions that enhance the efficiency and effectiveness of the cancer care continuum has never been more critical.
At the forefront of this transformation is the integration of artificial intelligence (AI) and deep-Health Tech, which offer groundbreaking opportunities to streamline cancer diagnosis, treatment, and follow-up care. These technologies can revolutionise oncology, but their full potential can only be unlocked within a sustainable framework. This requires healthcare systems to embrace models that reduce procedural redundancies, lower costs, and improve access to personalised care—all while ensuring long-term efficiency.
A key focus of the conference will be the development of sustainable system solutions that integrate AI into clinical oncology. These discussions will emphasise the importance of maintaining affordability and accessibility, ensuring that healthcare systems are equipped to manage the rising cancer burden while easing the financial and emotional strain on patients.
The long-term success of these innovations will rely heavily on robust policy frameworks. As AI-driven technologies become more prevalent, policies must evolve to ensure patient safety, uphold ethical standards, and comply with regulatory requirements. BJCN-MORE 2024 will bring together policymakers, healthcare innovators, and industry leaders to explore how to develop and implement these frameworks, ensuring AI’s safe and effective integration into the healthcare system.
A highlight of the conference will be the exploration of ECHoS (Establishing Cancer Mission Hubs: Networks and Synergies), an initiative that seeks to create national cancer mission hubs. This approach will centralise expertise, foster collaboration, and drive innovation across cancer care systems. By adopting ECHoS best practices, Bulgaria has the opportunity to establish a National Cancer Mission Hub, positioning itself as a leader in sustainable, patient-centered cancer care.